- Joined
- Mar 26, 2009
- Messages
- 75
- Reaction score
- 45
Fellow Radoncers-
An update regarding some advocacy work we have been working on through the AMA for our patients.
The problem: Standard-of-care is for us to discuss with our patients, especially the AYAs (adolescent and young adults- 15-39 year-olds) the effects of treatment on fertility, and fertility preservation options (oncofertility). We think we are doing a good job (http://www.practicalradonc.org/article/S1879-8500%2811%2900356-0/abstract) though the raw numbers, that only 2-4% of women actually get fertility preservation therapy, tell us a very different story (http://onlinelibrary.wiley.com/doi/10.1002/cncr.26649/abstract and (http://jco.ascopubs.org/content/30/17/2147.full)
One of the primary barriers for our patients is that insurance carriers will not routinely cover oncofertilty- even in states with mandated infertility coverage. To this end we presented a resolution at this year's AMA annual meeting that our AMA create policy such that oncfertility be included in coverage by all payers. We built a large coalition with oncologic, women's health and some state societies supporting the resolution. It was passed by the AMA Residents and Fellows section (RFS) and immediately forwarded to the AMA House of Delegates (HOD).
After some lively discussion and debate, a decision was made to reaffirm a broad AMA policy D-330.918 in lieu of our resolution (i.e., AMA policy D-330.918 Appropriateness of National Coverage Decisions 1. Our AMA will work with the national medical specialty societies and the Centers for Medicare and Medicaid Services (CMS) and their intermediaries to identify outdated coverage decisions that create obstacles to clinically appropriate patient care.)
It was an exciting week -- we managed to create significant awareness, dialogue and debate about this very important and timely issue. On our side, we will continue to work with the specialty and state societies to further advocate this cause for our patients. Our goal is to remove the obstacles they face in receiving the care they need.
Overall it was a great experience- working the policy route to actively help our patients. Please let me know if you have any interest in helping move this issue forward.
[Plug Alert] Also, if there are any other cracks in our system you want to see fixed - get involved with the AMA and use this powerful venue! You can join the AMA as a resident member for $45 (http://www.ama-assn.org/ama/pub/membership.page). Many of us will have membership covered by their institution or state societies- so dont hesitate to ask.
Personal benefits of becoming a member: JAMA subscription and many leadership opportunities on a state and national level.
Radiation Oncology benefit: This will also help ensure that ASTRO maintains a delegate in the general House of Delegates, Young Physician Section, and Resident and Fellow Section.
An update regarding some advocacy work we have been working on through the AMA for our patients.
The problem: Standard-of-care is for us to discuss with our patients, especially the AYAs (adolescent and young adults- 15-39 year-olds) the effects of treatment on fertility, and fertility preservation options (oncofertility). We think we are doing a good job (http://www.practicalradonc.org/article/S1879-8500%2811%2900356-0/abstract) though the raw numbers, that only 2-4% of women actually get fertility preservation therapy, tell us a very different story (http://onlinelibrary.wiley.com/doi/10.1002/cncr.26649/abstract and (http://jco.ascopubs.org/content/30/17/2147.full)
One of the primary barriers for our patients is that insurance carriers will not routinely cover oncofertilty- even in states with mandated infertility coverage. To this end we presented a resolution at this year's AMA annual meeting that our AMA create policy such that oncfertility be included in coverage by all payers. We built a large coalition with oncologic, women's health and some state societies supporting the resolution. It was passed by the AMA Residents and Fellows section (RFS) and immediately forwarded to the AMA House of Delegates (HOD).
After some lively discussion and debate, a decision was made to reaffirm a broad AMA policy D-330.918 in lieu of our resolution (i.e., AMA policy D-330.918 Appropriateness of National Coverage Decisions 1. Our AMA will work with the national medical specialty societies and the Centers for Medicare and Medicaid Services (CMS) and their intermediaries to identify outdated coverage decisions that create obstacles to clinically appropriate patient care.)
It was an exciting week -- we managed to create significant awareness, dialogue and debate about this very important and timely issue. On our side, we will continue to work with the specialty and state societies to further advocate this cause for our patients. Our goal is to remove the obstacles they face in receiving the care they need.
Overall it was a great experience- working the policy route to actively help our patients. Please let me know if you have any interest in helping move this issue forward.
[Plug Alert] Also, if there are any other cracks in our system you want to see fixed - get involved with the AMA and use this powerful venue! You can join the AMA as a resident member for $45 (http://www.ama-assn.org/ama/pub/membership.page). Many of us will have membership covered by their institution or state societies- so dont hesitate to ask.
Personal benefits of becoming a member: JAMA subscription and many leadership opportunities on a state and national level.
Radiation Oncology benefit: This will also help ensure that ASTRO maintains a delegate in the general House of Delegates, Young Physician Section, and Resident and Fellow Section.